Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2021

May 17, 2021

SELL
$109.18 - $185.98 $38.2 Million - $65.1 Million
-350,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $18.1 Million - $46.7 Million
275,000 Added 366.67%
350,000 $36.6 Million
Q3 2020

Nov 16, 2020

BUY
$54.34 - $94.85 $4.08 Million - $7.11 Million
75,000 New
75,000 $5.31 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.